Yüklüyor......
Homogeneous tumor targeting with a single dose of HER2-targeted albumin-binding domain-fused nanobody-drug conjugates results in long-lasting tumor remission in mice
Background: The non-homogenous distribution of antibody-drug conjugates (ADCs) within solid tumors is a major limiting factor for their wide clinical application. Nanobodies have been shown to rapidly penetrate into xenografts, achieving more homogeneous tumor targeting. However, their rapid renal c...
Kaydedildi:
| Yayımlandı: | Theranostics |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Ivyspring International Publisher
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8039960/ https://ncbi.nlm.nih.gov/pubmed/33859761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.57510 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|